Silliker Australia Pty Ltd t/a Merieux NutriSciences

Merieux Nutrisciences

Site

Sydney Microbiology Laboratory

Accreditation No.

2020

Site No.

2759

Date of Accreditation

16 Nov 1989

Address

Unit C2, Regents Park Estate, 391 Park Road
Regents Park, NSW 2143
Australia

merieuxnutrisciences.com/au

Contact

Mr Imtiaz Ahmed P: +61 (02) 87186838

Availability

Services available to external clients

Scope of Accreditation

Sydney Microbiology Laboratory

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique Procedure
Analysis for physical and chemical characteristics of cosmetics, perfumes and essentials oils Cosmetic products; Essential oils; Perfumes Bioburden Filtration ANSI/AMMI/ISO 11737-1; BS EN 1174.1 (in-house method M38)
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines Biological products; Pharmaceuticals Bioburden Filtration

BS EN 1174.1, ANSI/AMMI/ISO 11737-1 (in-house method M38)

Biological analysis of cosmetics, perfumes and essentials oils Cosmetic products; Essential oils; Perfumes Preservative efficacy Pour plate BP Appendix XVIC (in-house method M28)
USP Chapter <61> (in-house method M29)
Clostridium perfringens; Clostridium spp.​​​​; Enterobacteriaceae; Escherichia coli​​​​; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Coliforms; Spores; Yeasts and moulds Pour plate; Spread plate - Aerobic and anaerobic

FDA-BAM Chapter 23 (in-house methods M22, M24)

Indicator organisms; Spores Pour plate; Spread plate - Aerobic and anaerobic USP Chapter <55> (in-house method M25, M39)
Biological analysis of human and veterinary medicines including vaccines Antibiotics Bioassay Large plate diffusion assay in-house methods M87, M89, M90, M92, M93, M95, M96, M97, M98
Biological products; Pharmaceuticals Preservative efficacy Pour plate BP Appendix XVIC (in-house method M28)
USP Chapter <61> (in-house method M29)
Lactobacillus acidophilus; Lactobacillus spp. Pour plate; Spread plate in-house method M56
Clostridium perfringens; Clostridium spp.​​​​; Enterobacteriaceae; Escherichia coli​​​​; Lactobacillus acidophilus; Lactobacillus spp.; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Bacterial spores; Coliforms; Yeasts and moulds Membrane filter; Pour plate; Spread plate

FDA-BAM Chapter 23 (in-house methods M21, M22, M24, M65)

Biological analysis of medical devices Medical devices Clostridium perfringens; Clostridium spp.​​​​; Enterobacteriaceae; Escherichia coli​​​​; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Coliforms; Spores; Yeasts and moulds Pour plate in-house methods M21, M22, M24

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.